MKI67 and digestive system neuroendocrine tumor, grade 1/2: Currently, Ki-67 is only used in gastrointestinal neuroendocrine tumors, and is established as a predictive and therapeutical marker; however, it has not yet played a role in the management of CRCs, but our data suggest a predictive value for Ki-67 [7,16].